SecBot SecBot
6-K ·Filed Jul 1, 2026

HYFT

MindWalk Holdings Corp.
NEUTRAL
Impact 3/10
Horizonmonths Processed3mo ago SEC0001715925-26-000010
Notable filing: 6-K
Actionable Insight • Neutral

This patent filing is a routine IP step with no immediate revenue or earnings catalyst. Monitor for patent grant status and any future customer adoption announcements for LensAI or ReefIQ. The preclinical dengue and influenza data are early-stage and unlikely to drive near-term stock movement.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
HYFT ▼ -14.81% at T+60d
NEUTRAL call -14.81% · α vs SPY -18.25% · entry $1.62 → $1.38
Entry = T+0 close
Jul 1, 2026
via day close
T+1d
-3.09%
call -3.09% · α -2.96%
$1.57
settled 4mo ago
T+5d
-6.79%
call -6.79% · α -7.05%
$1.51
settled 4mo ago
T+20d
-19.75%
call -19.75% · α -17.57%
$1.30
settled 3mo ago
T+60d
-14.81%
call -14.81% · α -18.25%
$1.38
settled 5w ago

Price Chart

Loading chart...

Executive Summary

MindWalk Holdings filed a European patent application (EP26187897.9) for its high-dimensional biological data architecture, which underpins its HYFT Technology, ReefIQ, and LensAI platforms. The filing is a routine IP development step with no immediate financial impact, as the patent has not been granted and the company's programs remain preclinical.

Key Facts

  • Filed European patent application EP26187897.9 for high-dimensional biological data structures and property inference.
  • Patent covers the model-agnostic biological representation layer around HYFT pattern anchors, supporting ReefIQ and LensAI.
  • Company reports preclinical binding-level data in dengue and influenza programs, but these remain preclinical with no clinical or commercial data.
  • LensAI is in contracted, recurring arrangements with life-sciences customers; no revenue or financial details disclosed.
  • Biological representation includes 660 million patterns and 25 billion relationships.

Financial Impact

No financial figures reported; filing is a non-financial IP update.

Risk Factors

  • Patent may be narrowed, rejected, or challenged during prosecution.
  • Preclinical results may not translate to clinical or commercial success.
  • Customer adoption of AI platforms may be slower than expected.
  • Capital markets conditions and competition in AI drug discovery.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001715925-26-000010
Document: press_release_july_1_202.htm0001715925-26-000010
Document: 0001715925-26-000010-index-headers.html0001715925-26-000010
Document: 0001715925-26-000010-index.html0001715925-26-000010
Document: 0001715925-26-000010.txt0001715925-26-000010
15 reports for HYFT
Performance horizon
25% Hit rate @ T+20 1 of 4 directional calls Went positive at some point 2 of 4 best @ T+5▲ +10.53%Sep 14, 2026
Filters
Rows
Reports for HYFT — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
6-K
NEUTRAL ★ 3/10
$1.16awaiting T+20—$1.15 (−0.86%)
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 3/10
$1.27awaiting T+20—$1.15 (−9.45%)
Oct 14, 2026
12d ago
6-K
NEUTRAL ★ 3/10
$1.37awaiting T+20—$1.15 (−16.06%)
Oct 6, 2026
20d ago
6-K
NEUTRAL ★ 3/10
$1.55awaiting T+20—$1.15 (−25.81%)
Sep 21, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$1.47 $1.32▼ −10.20%▼ −9.30%$1.15 (−21.77%)
Sep 14, 2026
6w ago
6-K
BEARISH ★ 7/10
$1.16 $1.48▼ −28.14%▼ −25.16%$1.15 (+0.43%)
Sep 14, 2026
6w ago
6-K
BULLISH ★ 6/10
$1.33 $1.40▲ +5.26%▲ +3.00%$1.15 (−13.53%)
Jul 31, 2026
12w ago
EFFECT
NEUTRAL ★ 2/10
$1.29 $1.39▲ +7.75%▲ +4.76%$1.15 (−10.85%)
Jul 6, 2026
16w ago
6-K
BULLISH ★ 5/10
$1.64 $1.29▼ −21.34%▼ −20.78%$1.15 (−29.88%)
Jul 1, 2026
16w ago
6-K
NEUTRAL ★ 3/10
$1.62 $1.30▼ −19.75%▼ −17.57%$1.15 (−29.01%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 4h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 1, 2026